INDI Trademark

Trademark Overview

On Friday, April 29, 2011, a trademark application was filed for INDI with the United States Patent and Trademark Office. The USPTO has given the INDI trademark a serial number of 85308924. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 20, 2020. This trademark is owned by Integrated Diagnostics, Inc.. The INDI trademark is filed in the Pharmaceutical Products category with the following description:

Biochemical preparations for medical diagnostic use for use in quantitative detection measured in blood, human fluids, mammalian tissue samples, CSF and other mammalian body fluids, namely, protein capture agents, antibodies, buffer solutions used in analytical chemistry, biochemical reagents, RNA transcription and microRNA expression assays; biochemical preparations for medical use for use in small molecule analysis in the nature of detection of protein levels in blood and human fluids, for diagnostic, therapeutic and imaging uses; diagnostic kits for medical diagnostic purposes consisting primarily of protein capture agents and antibodies, buffers, and reagents for use in detecting Alzheimer's disease, cancer and central nervous system disorders; diagnostic kits for medical diagnostic purposes consisting primarily of protein capture agents and antibodies, buffers, and reagents for use in disease testing, health monitoring and more generally, predictive, preventive, personalized, and ...
indi

General Information

Serial Number85308924
Word MarkINDI
Filing DateFriday, April 29, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 20, 2020
Registration Number4384433
Registration DateTuesday, August 13, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 5, 2013

Trademark Statements

Goods and ServicesBiochemical preparations for medical diagnostic use for use in quantitative detection measured in blood, human fluids, mammalian tissue samples, CSF and other mammalian body fluids, namely, protein capture agents, antibodies, buffer solutions used in analytical chemistry, biochemical reagents, RNA transcription and microRNA expression assays; biochemical preparations for medical use for use in small molecule analysis in the nature of detection of protein levels in blood and human fluids, for diagnostic, therapeutic and imaging uses; diagnostic kits for medical diagnostic purposes consisting primarily of protein capture agents and antibodies, buffers, and reagents for use in detecting Alzheimer's disease, cancer and central nervous system disorders; diagnostic kits for medical diagnostic purposes consisting primarily of protein capture agents and antibodies, buffers, and reagents for use in disease testing, health monitoring and more generally, predictive, preventive, personalized, and participatory medicine all in the fields of detecting blood disorders and detecting cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 20, 2020
Primary Code005
First Use Anywhere DateFriday, June 10, 2011
First Use In Commerce DateFriday, June 10, 2011

Trademark Owner History

Party NameBIODESIX, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBOULDER, CO 80301
Party NameIntegrated Diagnostics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98101
Party NameIntegrated Diagnostics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109
Party NameIntegrated Diagnostics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Trademark Events

Event DateEvent Description
Friday, March 20, 2020CANCELLED SEC. 8 (6-YR)
Monday, October 22, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 22, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 13, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, August 1, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, April 11, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 11, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 11, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 11, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 5, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 5, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 13, 2013REGISTERED-PRINCIPAL REGISTER
Saturday, July 6, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, July 5, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Sunday, June 30, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 5, 2013STATEMENT OF USE PROCESSING COMPLETE
Monday, May 6, 2013USE AMENDMENT FILED
Friday, May 24, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 6, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, April 2, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 5, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 5, 2013PUBLISHED FOR OPPOSITION
Wednesday, January 16, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 3, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, December 31, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 29, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 28, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 28, 2012TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, October 31, 2012NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Wednesday, October 31, 2012CONTINUATION OF FINAL REFUSAL E-MAILED
Wednesday, October 31, 2012ACTION CONTINUING A FINAL - COMPLETED
Saturday, October 13, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 12, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 12, 2012TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, April 13, 2012NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, April 13, 2012FINAL REFUSAL E-MAILED
Friday, April 13, 2012FINAL REFUSAL WRITTEN
Tuesday, March 20, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 20, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 12, 2012ASSIGNED TO LIE
Wednesday, February 22, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 22, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 22, 2011NON-FINAL ACTION E-MAILED
Monday, August 22, 2011NON-FINAL ACTION WRITTEN
Wednesday, August 10, 2011ASSIGNED TO EXAMINER
Wednesday, May 4, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 3, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

indi diagnostic protein medical agents antibodies reagents fluids biochemical capture preparations